NPI: 1174551147 · CORAL SPRINGS, FL 33065 · General Acute Care Hospital · NPI assigned 06/29/2006
Authorized official BERT, ALISA controls 20+ related entities in our dataset. Read more
| Authorized Official | BERT, ALISA (INTERIM CFO) |
| Parent Organization | NORTH BROWARD HOSPITAL DISTRICT |
| NPI Enumeration Date | 06/29/2006 |
Other providers sharing the same authorized official: BERT, ALISA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 31,206 | $666K |
| 2019 | 129,763 | $2.56M |
| 2020 | 81,287 | $1.51M |
| 2021 | 117,737 | $3.12M |
| 2022 | 141,620 | $5.20M |
| 2023 | 89,282 | $3.65M |
| 2024 | 38,819 | $1.76M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 47,854 | 44,694 | $4.44M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 32,943 | 29,442 | $3.30M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11,517 | 3,228 | $956K |
| 59899 | 4,555 | 3,378 | $914K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,130 | 3,299 | $827K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,882 | 4,346 | $785K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,160 | 7,795 | $762K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 10,539 | 2,948 | $754K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8,161 | 7,640 | $662K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,947 | 2,600 | $598K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8,369 | 7,414 | $481K |
| 87631 | 2,959 | 2,863 | $386K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,463 | 1,263 | $269K |
| G0378 | Hospital observation service, per hour | 11,483 | 5,663 | $240K |
| 36415 | Collection of venous blood by venipuncture | 33,816 | 24,769 | $226K |
| E0700 | Safety equipment, device or accessory, any type | 615 | 457 | $217K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3,904 | 3,573 | $206K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,207 | 3,893 | $159K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 713 | 647 | $134K |
| 80053 | Comprehensive metabolic panel | 27,785 | 23,325 | $119K |
| 87070 | 8,141 | 7,734 | $108K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,852 | 10,894 | $88K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 15,969 | 13,919 | $85K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,173 | 3,755 | $84K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,056 | 5,483 | $82K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 397 | 362 | $79K |
| 71046 | Radiologic examination, chest; 2 views | 13,782 | 13,041 | $78K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,849 | 1,693 | $75K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,316 | 936 | $63K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,512 | 2,277 | $62K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,600 | 1,455 | $62K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 13,957 | 12,732 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 628 | 538 | $60K |
| 80048 | Basic metabolic panel (calcium, ionized) | 10,421 | 8,280 | $48K |
| 81001 | 22,250 | 20,105 | $47K | |
| 76775 | 791 | 735 | $44K | |
| 87486 | 1,632 | 1,559 | $39K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 932 | 711 | $38K |
| 97161 | 627 | 533 | $38K | |
| 74018 | 3,708 | 3,516 | $34K | |
| 76801 | 2,174 | 1,807 | $31K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 20,683 | 14,448 | $30K |
| 76830 | Ultrasound, transvaginal | 1,046 | 968 | $29K |
| 12011 | 397 | 372 | $29K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,393 | 1,279 | $29K |
| 76641 | 447 | 336 | $29K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40,413 | 31,790 | $28K |
| 81003 | 3,320 | 2,999 | $26K | |
| 71045 | Radiologic examination, chest; single view | 7,838 | 6,709 | $26K |
| 76818 | 1,268 | 1,041 | $25K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 47 | 44 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | 429 | 355 | $21K |
| 73564 | 800 | 624 | $18K | |
| 93976 | 918 | 852 | $17K | |
| 87420 | 2,282 | 2,218 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 868 | 742 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 179 | 170 | $15K |
| 73610 | 904 | 807 | $14K | |
| 73630 | 1,206 | 1,086 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,169 | 8,452 | $12K |
| 87507 | 74 | 73 | $12K | |
| 81025 | 3,227 | 3,021 | $12K | |
| 12001 | 162 | 156 | $12K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,291 | 1,113 | $11K |
| 73130 | 592 | 511 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 9,633 | 7,895 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 522 | 470 | $10K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 810 | 649 | $10K |
| 70486 | 83 | 78 | $10K | |
| 95819 | 106 | 101 | $9K | |
| 84702 | 3,810 | 3,023 | $9K | |
| 87077 | 1,369 | 1,183 | $8K | |
| 93971 | 489 | 425 | $8K | |
| 87040 | 8,729 | 7,767 | $8K | |
| 84484 | 6,117 | 4,309 | $8K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 146 | 141 | $8K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 111 | 109 | $7K |
| 97165 | 59 | 50 | $7K | |
| 73030 | 611 | 537 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,014 | 3,213 | $7K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,705 | 5,656 | $6K |
| 73110 | 513 | 448 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,113 | 6,914 | $6K |
| 87430 | 8,112 | 7,781 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 609 | 426 | $5K |
| 85610 | 4,265 | 3,413 | $5K | |
| 86850 | 1,424 | 1,204 | $5K | |
| 87210 | 684 | 642 | $4K | |
| 72100 | 650 | 602 | $4K | |
| 80061 | Lipid panel | 1,418 | 1,227 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,507 | 1,441 | $4K |
| 83605 | 2,696 | 2,147 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 14 | 12 | $4K |
| 83735 | 3,279 | 2,463 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,237 | 1,944 | $4K |
| 83690 | 7,883 | 6,870 | $3K | |
| J2704 | Injection, propofol, 10 mg | 1,857 | 1,600 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 507 | 404 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,751 | 1,329 | $3K |
| 76536 | 45 | 41 | $3K | |
| 86900 | 3,170 | 2,716 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 840 | 729 | $3K |
| 72131 | 41 | 29 | $3K | |
| 85730 | 3,463 | 2,851 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 6,604 | 5,374 | $2K |
| 80076 | 1,535 | 1,380 | $2K | |
| 92523 | 14 | 13 | $2K | |
| 86901 | 3,173 | 2,717 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,224 | 1,083 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 191 | 106 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 243 | 207 | $2K |
| 84703 | 7,216 | 6,525 | $2K | |
| 93970 | 36 | 29 | $2K | |
| 59025 | Fetal non-stress test | 14 | 13 | $1K |
| 87045 | 191 | 176 | $1K | |
| 97162 | 19 | 15 | $1K | |
| 83880 | 1,355 | 1,126 | $1K | |
| 73560 | 41 | 36 | $991.96 | |
| 86140 | 8,754 | 8,122 | $979.01 | |
| 70491 | 12 | 12 | $937.66 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,780 | 1,576 | $920.18 |
| 73090 | 105 | 88 | $879.51 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 317 | 300 | $867.29 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 865 | 813 | $824.21 |
| 82728 | 127 | 116 | $734.91 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 802 | 684 | $691.00 |
| 73070 | 31 | 24 | $689.48 | |
| 73140 | 172 | 155 | $688.24 | |
| 73590 | 105 | 86 | $610.41 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 371 | 334 | $600.81 |
| 87186 | 1,988 | 1,749 | $542.06 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 15 | 13 | $537.47 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,955 | 1,580 | $512.96 |
| 85379 | 1,260 | 1,148 | $487.68 | |
| 93975 | 45 | 42 | $472.12 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,014 | 843 | $425.49 |
| A9270 | Non-covered item or service | 1,082 | 423 | $420.98 |
| 72040 | 85 | 83 | $393.78 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 82 | 66 | $388.24 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 181 | 159 | $338.46 |
| 82550 | 2,163 | 1,868 | $327.03 | |
| 87581 | 1,632 | 1,559 | $325.53 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 313 | 296 | $311.80 |
| 95957 | 71 | 66 | $293.11 | |
| J7510 | Prednisolone oral, per 5 mg | 2,861 | 2,730 | $288.95 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,095 | 644 | $287.08 |
| 87205 | 266 | 229 | $282.55 | |
| 87088 | 1,299 | 1,152 | $274.96 | |
| 82150 | 1,141 | 1,088 | $184.92 | |
| 29125 | 76 | 72 | $169.38 | |
| 76870 | 30 | 27 | $148.27 | |
| C9113 | Injection, pantoprazole sodium, per vial | 297 | 134 | $126.86 |
| 70360 | 14 | 13 | $95.91 | |
| 84550 | 135 | 106 | $86.83 | |
| 85651 | 825 | 743 | $83.54 | |
| 96376 | 617 | 539 | $67.16 | |
| 84100 | 475 | 348 | $63.01 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,592 | 1,258 | $62.30 |
| 82746 | 13 | 12 | $46.29 | |
| 73080 | 43 | 38 | $38.61 | |
| 74019 | 17 | 16 | $35.85 | |
| 74022 | 16 | 12 | $35.85 | |
| J2060 | Injection, lorazepam, 2 mg | 500 | 383 | $25.99 |
| 86308 | 178 | 170 | $25.06 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 750 | 509 | $18.16 |
| 87046 | 214 | 176 | $17.42 | |
| 73502 | 14 | 12 | $15.71 | |
| 84439 | 33 | 28 | $14.29 | |
| 83615 | 262 | 219 | $10.94 | |
| 87147 | 121 | 112 | $10.78 | |
| J3490 | Unclassified drugs | 258 | 161 | $6.79 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 104 | 80 | $5.04 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 56 | 50 | $4.90 |
| 82553 | 73 | 57 | $4.90 | |
| 83540 | 14 | 14 | $4.72 | |
| 85046 | 36 | 24 | $2.94 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 35 | 26 | $0.98 |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,436 | 1,288 | $0.98 |
| 88312 | 16 | 12 | $0.76 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 2,369 | 2,263 | $0.00 |
| 36600 | 12 | 12 | $0.00 | |
| 94667 | 22 | 15 | $0.00 | |
| 85384 | 48 | 40 | $0.00 | |
| 90715 | 27 | 24 | $0.00 | |
| 29515 | 27 | 27 | $0.00 | |
| A4614 | Peak expiratory flow rate meter, hand held | 22 | 17 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 54 | 51 | $0.00 |
| 85007 | 12 | 12 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 229 | 120 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 32 | 26 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 301 | 300 | $0.00 |
| 82803 | 12 | 12 | $0.00 | |
| 85027 | 24 | 24 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 46 | 40 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 177 | 113 | $0.00 |
| J1741 | Injection, ibuprofen, 100 mg | 17 | 14 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 30 | 28 | $0.00 |
| 87425 | 29 | 25 | $0.00 | |
| 82607 | 15 | 12 | $0.00 |